![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Questex Acquires ExL Events
Questex, a leading global business information and events company announced it has acquired ExL Events,...
Bristol-Myers Squibb Acquires Cormorant Pharmaceuticals
Bristol-Myers Squibb Company and Cormorant Pharmaceuticals announced that Bristol-Myers Squibb has acquired all of the...
Pfizer Completes Acquisition Of Anacor Pharmaceuticals
Pfizer Inc announced that it has completed its acquisition of Anacor Pharmaceuticals, Inc. Under the...
Bristol-Myers Squibb to Announce Results for Second Quarter 2016 on July 28
Bristol-Myers Squibb Company will announce results for the second quarter of 2016 on Thursday, July...
Peregrine Pharmaceuticals Declares Quarterly Dividend on Its Series E Convertible Preferred Stock
Peregrine Pharmaceuticals, Inc announced that its Board of Directors has declared a quarterly cash dividend...
Merck to Hold Investor Briefing at 2016 ASCO Annual Meeting
Merck known as MSD outside the United States and Canada, announced that Dr. Roger M....
Thunderbolt Pharma, Inc , Vitesse Biologics Company, Acquires Rights to BAFF/APRIL Dual Antagonist Program...
Baxalta Incorporated , Velocity Pharmaceutical Development, LLC and Astellas Pharma Inc announced that Thunderbolt, Inc.,...
Merck Co Inc Announces Third-Quarter 2016 Dividend
Merck announced that the Board of Directors has declared a quarterly dividend of $0.46 per...
Merck Increases Sales and Earnings in Q1 Following Sigma-Aldrich Acquisition
Healthcare and Life Science drive Group organic sales growth (+4.7%) Sigma-Aldrich acquisition fuels sales...
Pfizer To Acquire Anacor
Strong fit with Pfizer’s Inflammation and Immunology portfolio Expected to enhance near-term revenue growth...